Targeted Medical Pharma, Inc. (OTCMKTS:TRGM – Get Free Report)’s stock price crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $0.00 and traded as high as $0.00. Targeted Medical Pharma shares last traded at $0.00, with a volume of 0 shares changing hands.
Targeted Medical Pharma Stock Performance
About Targeted Medical Pharma
Targeted Medical Pharma, Inc, a specialty pharmaceutical company, doing business as Physician Therapeutics, develops and commercializes amino acid based medications to physicians, pharmacies, and patients in the United States. It offers a line of patented amino acid based medical food products, dietary supplements, and generic drugs primarily for the treatment of metabolic syndrome/obesity; sleep disorders associated with anxiety; hypertension; viral infections; cognitive disorders/fatigue; sleep disorders associated with depression, fibromyalgia, and PTSD; pain disorders and inflammatory conditions/fibromyalgia; osteoarthritis and joint disorders; and peripheral neuropathy.
See Also
- Five stocks we like better than Targeted Medical Pharma
- 3 Monster Growth Stocks to Buy Now
- Disney: Forging a 3-Headed Sports Streaming Giant With Fubo Deal
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- How Buffett’s Best and Worst Stock Bets Have Fared 5 Years Later
- Airline Stocks – Top Airline Stocks to Buy Now
- Bill Ackman’s Bold Case for Fannie Mae and Freddie Mac
Receive News & Ratings for Targeted Medical Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Targeted Medical Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
